POLL: Which 2022 Psoriasis FDA Approval Were You Most Excited About?

Poll

Click here to answer this week's poll.

Which 2022 Psoriasis FDA Approval Were You Most Excited About?

Deucravacitinib
Tapinarof cream
Roflumilast cream
Spesolimab (generalized pustular psoriasis)
Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.